Results of tadalafil treatment in patients following an open nerve-sparing radical prostatectomy

ArticleAçık Erişim

Özet

Purpose: To evaluate the effect of postoperatively administering a low daily dose of tadalafil on the erectile function of patients who underwent a nerve-sparing radical prostatectomy(NSRP) due to localized prostate cancer (PCa). Materials and Methods: Of 138 patients, who underwent NSRP due to PCa between 2012 and 2014, 55 patients who had not had pre-operative erectile dysfunction (ED) were included in the study. The mean age of the patients was 64 (54-72). On the 15th day after surgery, after ultrasound evaluation, all 55 patients started on a daily dose of 5 mg tadalafil that was continued for 2.5 months. The erectile function of patients was evaluated pre-operatively, post-operatively, and at the 3rd and 6th month after surgery using the International Index of Erectile Function (IIEF-5) test. None of the patients was treated with hormonal therapy or radiotherapy before or after surgery. Results: Three patients were excluded from the study due to the adverse effects of tadalafil and two patients elected to discontinue the treatment. Of the remaining 50 patients whose pre-operative erectile function had been found normal, at 3 months after surgery, 36 (72%) had normal erectile function; of the remaining patients in the study six (12%) presented with mild, two (4%) with moderate, and six (12%) with severe ED. Six months after surgery, 35 patients (70%) had normal erectile function while seven (14%) had mild, three (6%) moderate and five (10%) severe ED. There was no statistically significant difference between the results obtained at the 3rd and 6thmonth follow-up (p > 0.05). Three patients reported adverse effects with tadalafil including flushes in 2 (3.6%) and a headache in 1 (1.8%). Conclusions: The administration of a 5 mg post-operative dose of tadalafil to patients that had undergone a bilateral NSRP was found to have a positive effect on the recovery and maintenance of erectile function. However, there is still a need to investigate a larger series of cases.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/15464Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.4081/aiua.2016.1.4Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorHirik, Erkan
dc.contributor.authorBozkurt, Aliseydi
dc.contributor.authorKarabakan, Mehmet
dc.contributor.authorOnuk, Özkan
dc.contributor.authorBalci, Mustafa Bahadir Can
dc.contributor.authorAydin, Memduh
dc.contributor.authorÇakan, Murat
dc.contributor.authorNuhoglu, Baris
dc.date.accessioned2026-10-18T20:30:18.543414852Z
dc.date.available2026-10-18T20:30:18.543414852Z
dc.date.issued2016
dc.description.abstractPurpose: To evaluate the effect of postoperatively administering a low daily dose of tadalafil on the erectile function of patients who underwent a nerve-sparing radical prostatectomy(NSRP) due to localized prostate cancer (PCa). Materials and Methods: Of 138 patients, who underwent NSRP due to PCa between 2012 and 2014, 55 patients who had not had pre-operative erectile dysfunction (ED) were included in the study. The mean age of the patients was 64 (54-72). On the 15th day after surgery, after ultrasound evaluation, all 55 patients started on a daily dose of 5 mg tadalafil that was continued for 2.5 months. The erectile function of patients was evaluated pre-operatively, post-operatively, and at the 3rd and 6th month after surgery using the International Index of Erectile Function (IIEF-5) test. None of the patients was treated with hormonal therapy or radiotherapy before or after surgery. Results: Three patients were excluded from the study due to the adverse effects of tadalafil and two patients elected to discontinue the treatment. Of the remaining 50 patients whose pre-operative erectile function had been found normal, at 3 months after surgery, 36 (72%) had normal erectile function; of the remaining patients in the study six (12%) presented with mild, two (4%) with moderate, and six (12%) with severe ED. Six months after surgery, 35 patients (70%) had normal erectile function while seven (14%) had mild, three (6%) moderate and five (10%) severe ED. There was no statistically significant difference between the results obtained at the 3rd and 6thmonth follow-up (p > 0.05). Three patients reported adverse effects with tadalafil including flushes in 2 (3.6%) and a headache in 1 (1.8%). Conclusions: The administration of a 5 mg post-operative dose of tadalafil to patients that had undergone a bilateral NSRP was found to have a positive effect on the recovery and maintenance of erectile function. However, there is still a need to investigate a larger series of cases.
dc.identifier.doi10.4081/aiua.2016.1.4
dc.identifier.eissn2282-4197
dc.identifier.endpage6
dc.identifier.issn1124-3562
dc.identifier.issue1
dc.identifier.pmid27072168
dc.identifier.scopus2-s2.0-84977765551
dc.identifier.startpage4
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/15464
dc.identifier.volume88
dc.identifier.wosWOS:000406050000002
dc.language.isoen
dc.publisherEdizioni Scripta Manent s.n.c.
dc.relation.ispartofArchivio Italiano di Urologia e Andrologia
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectErectile function.
dc.subjectRadical prostatectomy
dc.subjectTadalafil
dc.subjectAged
dc.subjectErectile Dysfunction
dc.subjectHumans
dc.subjectMale
dc.subjectMiddle Aged
dc.subjectPenile Erection
dc.subjectPhosphodiesterase 5 Inhibitors
dc.subjectProstatectomy
dc.subjectProstatic Neoplasms
dc.subjectTreatment Outcome
dc.subjectphosphodiesterase V inhibitor
dc.subjectadult
dc.subjectArticle
dc.subjectdisease severity
dc.subjectdrug efficacy
dc.subjectdrug safety
dc.subjectfollow up
dc.subjectheadache
dc.subjecthot flush
dc.subjecthuman
dc.subjectlow drug dose
dc.subjectmajor clinical study
dc.subjectnerve sparing radical prostatectomy
dc.subjectpenis erection
dc.subjectpostoperative care
dc.subjectpostoperative period
dc.subjectpreoperative evaluation
dc.titleResults of tadalafil treatment in patients following an open nerve-sparing radical prostatectomy
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus1
rdl.citation.wos0
rdl.departmentErzincan University Mengücek Gazi Education and Research Hospital, Urology Clinic. ehirik@gmail.com.
rdl.oa.statusgold
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexEmerging Sources Citation Index (ESCI)